TY - CHAP
T1 - Cellular and Molecular Effects of Obesity on the Heart
AU - Sultan, Ahmed
AU - Singh, Jaipaul
AU - Howarth, Frank Christopher
N1 - Publisher Copyright:
© Springer Nature Switzerland AG 2021.
PY - 2021
Y1 - 2021
N2 - Obesity is a serious chronic diseaseChronic diseases that is responsible for a large number of deaths worldwide. The Body Mass IndexBody mass index (BMI) (BMI) is widely used to provide definitions of overweightOverweight and obesity. A BMI of 20–24 is considered normal, a BMI of 25–29 is considered overweight and a BMI of 30 and over is considered obese. Overweight and obesity are attributed to a variety of risk factors including smoking, geneticsGenetics, alcohol consumption, high level of stress, physical inactivityPhysical inactivity, unhealthy dietDiet containing excessive amounts of fat and sugar, food snacking and binging, low calorie expenditure, socio-economic and psychological issues and some medications. OverweightOverweight and obesity are also associated with various illnesses including hormonal imbalanceHormonal imbalance, hypothyroidism, insulin resistanceInsulin resistance (IR), polycystic ovary syndrome and Cushing’s syndrome. Obesity is a risk factor for diabetesDiabetes(diabesityDiabesity) resulting in hyperglycemia which enhances the generation of reactive carbonyl species (RCS) and reactive oxygen speciesReactive oxygen species (ROS) in the myocardium. Both ROS and RCS elicit insults to cardiac muscle which may result in apoptosis, fibrosisFibrosis, hypertrophy, mitochondrial dysfunction, derangement in cellular calcium homeostasis and electrical signaling. In response to these insults the heart goes through a process of remodeling in order to maintain the demands of the body. Over time there may be development of cardiomyopathyCardiomyopathy, reduced ejection fractionEjection fraction and perhaps arrhythmias and sudden cardiac death (SCD). In general obesity is a preventable illness. This review describes the cellular and molecular effects of obesity on the heart leading to SCD.
AB - Obesity is a serious chronic diseaseChronic diseases that is responsible for a large number of deaths worldwide. The Body Mass IndexBody mass index (BMI) (BMI) is widely used to provide definitions of overweightOverweight and obesity. A BMI of 20–24 is considered normal, a BMI of 25–29 is considered overweight and a BMI of 30 and over is considered obese. Overweight and obesity are attributed to a variety of risk factors including smoking, geneticsGenetics, alcohol consumption, high level of stress, physical inactivityPhysical inactivity, unhealthy dietDiet containing excessive amounts of fat and sugar, food snacking and binging, low calorie expenditure, socio-economic and psychological issues and some medications. OverweightOverweight and obesity are also associated with various illnesses including hormonal imbalanceHormonal imbalance, hypothyroidism, insulin resistanceInsulin resistance (IR), polycystic ovary syndrome and Cushing’s syndrome. Obesity is a risk factor for diabetesDiabetes(diabesityDiabesity) resulting in hyperglycemia which enhances the generation of reactive carbonyl species (RCS) and reactive oxygen speciesReactive oxygen species (ROS) in the myocardium. Both ROS and RCS elicit insults to cardiac muscle which may result in apoptosis, fibrosisFibrosis, hypertrophy, mitochondrial dysfunction, derangement in cellular calcium homeostasis and electrical signaling. In response to these insults the heart goes through a process of remodeling in order to maintain the demands of the body. Over time there may be development of cardiomyopathyCardiomyopathy, reduced ejection fractionEjection fraction and perhaps arrhythmias and sudden cardiac death (SCD). In general obesity is a preventable illness. This review describes the cellular and molecular effects of obesity on the heart leading to SCD.
KW - BMI
KW - Cardiomyopathy
KW - Diabetes
KW - Heart
KW - Obesity
KW - Risk factors
UR - https://www.scopus.com/pages/publications/105006000945
UR - https://www.scopus.com/inward/citedby.url?scp=105006000945&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-84763-0_8
DO - 10.1007/978-3-030-84763-0_8
M3 - Chapter
AN - SCOPUS:105006000945
T3 - Advances in Biochemistry in Health and Disease
SP - 167
EP - 183
BT - Advances in Biochemistry in Health and Disease
PB - Springer Nature
ER -